Nuformix (NFX)

Sector:

Pharma and Biotech

0.13p
   
  • Change Today:
      0.005p
  • 52 Week High: 0.22
  • 52 Week Low: 0.048
  • Currency: UK Pounds
  • Shares Issued: 1,669.31m
  • Volume: 20,438,005
  • Market Cap: £2.17m
  • RiskGrade: 322

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
63.38% below the market average63.38% below the market average63.38% below the market average63.38% below the market average63.38% below the market average
21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
20.31% below the market average20.31% below the market average20.31% below the market average20.31% below the market average20.31% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Chg 3m
97.41% above the market average97.41% above the market average97.41% above the market average97.41% above the market average97.41% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
39.96% below the market average39.96% below the market average39.96% below the market average39.96% below the market average39.96% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Momentum 20
39.52% below the market average39.52% below the market average39.52% below the market average39.52% below the market average39.52% below the market average
36.36% below the sector average36.36% below the sector average36.36% below the sector average36.36% below the sector average36.36% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE
98.41% above the market average98.41% above the market average98.41% above the market average98.41% above the market average98.41% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
69.35% below the market average69.35% below the market average69.35% below the market average69.35% below the market average69.35% below the market average
8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
98.47% below the market average98.47% below the market average98.47% below the market average98.47% below the market average98.47% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Cash
96.24% below the market average96.24% below the market average96.24% below the market average96.24% below the market average96.24% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
54.22% below the market average54.22% below the market average54.22% below the market average54.22% below the market average54.22% below the market average
62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Nuformix Market Data

Currency UK Pounds
Share Price 0.13p
Change Today 0.005p
% Change 4.00 %
52 Week High 0.22
52 Week Low 0.048
Volume 20,438,005
Shares Issued 1,669.31m
Market Cap £2.17m
RiskGrade 322

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.47% below the market average38.47% below the market average38.47% below the market average38.47% below the market average38.47% below the market average
20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average20.83% above the sector average
Price Trend
10.99% below the market average10.99% below the market average10.99% below the market average10.99% below the market average10.99% below the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Income Not Available
Growth Not Available

Nuformix Dividends

No dividends found

Trades for 09-May-2025

Time Volume / Share Price
15:10 5,000,000 @ 0.13p
15:41 1,000,000 @ 0.14p
15:30 422,022 @ 0.14p
15:19 684,976 @ 0.14p
15:15 1,815,024 @ 0.14p

Top of Page